IUCD Complication
9
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
33%
3 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Clinical and Ultrasonographic Predictors of IUD Related Complications
Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System
Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography
Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion
Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System
Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women
Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion
Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion